Photodynamic Therapy for Esophageal Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Photodynamic therapy, a curative local treatment for esophageal squamous cell carcinoma, involves a photosensitizing drug(photosensitizer) with affinity for tumors and a photodynamic reaction triggered by laser light. Previously, photodynamic therapywas used to treat superficial esophageal squamous cell carcinoma judged to be difficult to undergo endoscopic resection. Recently,photodynamic therapy has mainly been performed for local failure after chemoradiotherapy. Although surgery is the most promisingtreatment for local failure after chemoradiotherapy, its morbidity and mortality rates are high. Endoscopic resection is feasible forlocal failure after chemoradiotherapy but requires advanced skills, and its indication is limited to within the submucosal layer bydepth. Photodynamic therapy is less invasive than surgery and has a wider indication than endoscopic resection. Porfimer sodium(a first-generation photosensitizer) causes a high frequency of side effects related to photosensitivity and requires the long-termsun-shade period. Talaporfin (a second-generation photosensitizer) requires a much shorter sun-shade period than porfimersodium. Photodynamic therapy will profoundly change treatment strategies for local failure after chemoradiotherapy.
Abstract
Photodynamic therapy, a curative local treatment for esophageal squamous cell carcinoma, involves a photosensitizing drug(photosensitizer) with affinity for tumors and a photodynamic reaction triggered by laser light. Previously, photodynamic therapywas used to treat superficial esophageal squamous cell carcinoma judged to be difficult to undergo endoscopic resection. Recently,photodynamic therapy has mainly been performed for local failure after chemoradiotherapy. Although surgery is the most promisingtreatment for local failure after chemoradiotherapy, its morbidity and mortality rates are high. Endoscopic resection is feasible forlocal failure after chemoradiotherapy but requires advanced skills, and its indication is limited to within the submucosal layer bydepth. Photodynamic therapy is less invasive than surgery and has a wider indication than endoscopic resection. Porfimer sodium(a first-generation photosensitizer) causes a high frequency of side effects related to photosensitivity and requires the long-termsun-shade period. Talaporfin (a second-generation photosensitizer) requires a much shorter sun-shade period than porfimersodium. Photodynamic therapy will profoundly change treatment strategies for local failure after chemoradiotherapy.
참고문헌 (28)
- Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- Dougherty TJ, "Photodynamic therapy", J Natl Cancer Inst, 90, pp.889~905 (1998)
- Fingar VH, "Vascular effects of photodynamic therapy", J Clin Laser Med Surg, 14, pp.323~328 (1996)
- Dougherty TJ, "Photoradiation therapy for the treatment of malignant tumors", Cancer Res, 38, pp.2628~2635 (1978)
- Yano T, "Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma : a phase II study", Int J Cancer, 131, pp.1228~1234 (2012)
- Kato H, "Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung", Lung Cancer, 42, pp.103~111 (2003)
- Yano T, "A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium(ME2906)and a diode laser(PNL6405EPG)for local failure after chemoradiotherapy or radiotherapy for esophageal cancer", Oncotarget, 8, pp.22135~22144 (2017)
- "Gan To Kagaku Ryoho", 1993, 2063~2066
- Nakamura T, "Photodynamic therapy of superficial esophageal cancer with a transparent hood", Gastrointest Endosc, 60, pp.120~124 (2004)
- Tanaka T, "Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus", Gastrointest Endosc, 73, pp.1~6 (2011)
- Inoue H, "Endoscopic esophageal mucosal resection using a transparent tube", Surg Endosc, 4, pp.198~201 (1990)
- Inoue H, "Endoscopic resection of early-stage esophageal cancer", Surg Endosc, 5, pp.59~62 (1991)
- Oyama T, "Endoscopic submucosal dissection of early esophageal cancer", Clin Gastroenterol Hepatol, 3(7 Suppl 1), pp.S67~S70 (2005)
- Ono S, "Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms", Gastrointest Endosc, 70, pp.860~866 (2009)
- Ishihara R, "Endoscopic submucosal dissection", endoscopic mucosal resection guidelines for esophageal cancer, 2020, pp.32, 452~493
- Kato H, "A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group Study(JCOG9708)", Jpn J Clin Oncol, 39, pp.638~643 (2009)
- Kato K, "Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma : JCOG trial(JCOG 9906)", Int J Radiat Oncol Biol Phys, 81, pp.684~690 (2011)
- Cooper JS, "Chemoradiotherapy of locally advanced esophageal cancer : long-term follow-up of a prospective randomized trial(RTOG 85-01). Radiation Therapy Oncology Group", JAMA, 281, pp.1623~1627 (1999)
- Minsky BD, "INT 0123(Radiation therapy oncology group 94-05)phase III trial of combined-modality therapy for esophageal cancer : high-dose versus standard-dose radiation therapy", J Clin Oncol, 20, pp.1167~1174 (2002)
- Swisher SG, "Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy", J Thorac Cardiovasc Surg, 123, pp.175~183 (2002)
- Swisher SG, "Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer", J Thorac Cardiovasc Surg, 119, pp.1126~1132 (2000)
- Onozawa M, "Elective nodal irradiation(ENI)in definitive chemoradiotherapy(CRT)for squamous cell carcinoma of the thoracic esophagus", Radiother Oncol, 92, pp.266~269 (2009)
- Hatogai K, "Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma", Gastrointest Endosc, 83, pp.1130~1139 (2016)
- Yano T, "Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma", Endoscopy, 40, pp.717~721 (2008)
- Kato H, "Photodynamic therapy for cancers : a clinical trial of porfimer sodium in Japan", Jpn J Cancer Res, 84, pp.1209~1214 (1993)
- Kessel D, "Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients", J Photochem Photobiol B, 39, pp.81~83 (1997)
- Minamide T, "Advantages of salvage photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer", Surg Endosc, 34, pp.899~906 (2020)